Follow
Maartje C.A. Wouters
Maartje C.A. Wouters
Freelance Medical Writer
Verified email at bccrc.ca - Homepage
Title
Cited by
Cited by
Year
Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer
MCA Wouters, BH Nelson
Clinical Cancer Research 24 (24), 6125-6135, 2018
3562018
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and …
E van Schooneveld, MCA Wouters, I Van der Auwera, DJ Peeters, ...
Breast cancer research 14, 1-16, 2012
2212012
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
EM Dijkgraaf, S Santegoets, AKL Reyners, R Goedemans, MCA Wouters, ...
Annals of Oncology 26 (10), 2141-2149, 2015
1582015
A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
HH Workel, JM Lubbers, R Arnold, TM Prins, P van der Vlies, K de Lange, ...
Cancer immunology research 7 (5), 784-796, 2019
1532019
CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
HH Workel, FL Komdeur, MCA Wouters, A Plat, HG Klip, FA Eggink, ...
European journal of cancer 60, 1-11, 2016
1422016
Treatment regimen, surgical outcome, and T-cell differentiation influence prognostic benefit of tumor-infiltrating lymphocytes in high-grade serous ovarian cancer
MCA Wouters, FL Komdeur, HH Workel, HG Klip, A Plat, NM Kooi, ...
Clinical Cancer Research 22 (3), 714-724, 2016
832016
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
FL Komdeur, MCA Wouters, HH Workel, AM Tijans, ALJ Terwindt, ...
Oncotarget 7 (46), 75130, 2016
792016
Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with exceptional survival in high-grade serous ovarian cancer
DW Garsed, K Alsop, S Fereday, C Emmanuel, CJ Kennedy, ...
Clinical Cancer Research 24 (3), 569-580, 2018
742018
Single-cell profiles and prognostic impact of tumor-infiltrating lymphocytes coexpressing CD39, CD103, and PD-1 in ovarian cancer
CM Laumont, MCA Wouters, J Smazynski, NS Gierc, EA Chavez, ...
Clinical Cancer Research 27 (14), 4089-4100, 2021
562021
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
MCA Wouters, EM Dijkgraaf, ML Kuijjer, ES Jordanova, H Hollema, ...
Oncoimmunology 3 (12), e962397, 2014
392014
CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer
M de Bruyn, VR Wiersma, MCA Wouters, DF Samplonius, HG Klip, ...
Oncoimmunology 4 (4), e999536, 2015
322015
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity
VR Wiersma, M de Bruyn, C Shi, MJM Gooden, MCA Wouters, ...
MAbs 7 (2), 321-330, 2015
302015
Cancer immunotherapy principles and practice
LH Butterfield, HL Kaufman, FM Marincola
Springer Publishing Company, 2021
282021
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers
J Smazynski, PT Hamilton, S Thornton, K Milne, MCA Wouters, JR Webb, ...
Gynecologic Oncology 158 (1), 167-177, 2020
252020
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome
KL Brunekreeft, ST Paijens, MCA Wouters, FL Komdeur, FA Eggink, ...
Oncoimmunology 9 (1), 1760705, 2020
122020
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer
AC Banville, MCA Wouters, AL Oberg, KM Goergen, MJ Maurer, K Milne, ...
Gynecologic oncology 160 (2), 520-529, 2021
102021
Size matters: survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation
MCA Wouters, FL Komdeur, M de Bruyn, HW Nijman
Oncoimmunology 5 (5), e1122863, 2016
82016
Nadia Traficante, for the Australian Ovarian Cancer Study Group: Homologous recombination DNA repair pathway disruption and retinoblastoma protein loss are associated with …
DW Garsed, K Alsop, S Fereday, C Emmanuel, CJ Kennedy, ...
Clin Cancer Res 24, 569-580, 2018
62018
What Is Flow Cytometry?
M Wouters
21980
The efficacy and tolerability of intermittent prandial acarbose to reduce glucose spikes in healthy individuals
A Isman, A Nyquist, M Moel, X Zhang, S Zalzala
Translational Medicine of Aging 7, 12-19, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20